Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P10
Near historical low
vs 3Y Ago
-29.2x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -51.08% |
| Q3 2025 | -63.30% |
| Q2 2025 | -120.80% |
| Q1 2025 | 1176.88% |
| Q4 2024 | 60.34% |
| Q3 2024 | -2.86% |
| Q2 2024 | 2.57% |
| Q1 2024 | 2.17% |
| Q4 2023 | -9.84% |
| Q3 2023 | 19.94% |
| Q2 2023 | -35.97% |
| Q1 2023 | 12.12% |
| Q4 2022 | 1.75% |
| Q3 2022 | -5.92% |
| Q2 2022 | -0.01% |
| Q1 2022 | -0.82% |
| Q4 2021 | -8.19% |
| Q3 2021 | -2.87% |
| Q2 2021 | -30.81% |
| Q1 2021 | -15.33% |
| Q4 2020 | -6.41% |
| Q3 2020 | -5.59% |
| Q2 2020 | -17.39% |
| Q1 2020 | -8.65% |
| Q4 2019 | -18.08% |
| Q3 2019 | -10.04% |
| Q2 2019 | -36.17% |
| Q1 2019 | -34.10% |
| Q4 2018 | -29.09% |
| Q3 2018 | -10.20% |
| Q2 2018 | -57.43% |
| Q1 2018 | 0.00% |